Ironwood Pharma (IRWD) Tops Q1 EPS by 3c, Revenues Miss; Offers FY21 Revenues Guidance Above Consensus
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/4/2026
- Wall Street ends higher after Democrats win Congress; data center stocks tumble
- What the Democratic sweep in the midterms means for markets
- SpaceX, Tesla slide as election risks mount, Morgan Stanley turns bullish
- CVS Health plans to split into two public companies by 2028
- AI sector outlook darkens as Democrat wins threaten $900B capex cycle
| IRONWOOD PHARMA-A (NASDAQ: IRWD) | Delayed: 3.77 +0.27 (7.71%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $3.50 | 52 Week High | $16.89 | |||
| Open | $3.61 | 52 Week Low | $7.35 | |||
| Day High | $3.80 | P/E | N/A | |||
| Day Low | $3.58 | EPS | $-2.35 | |||
| Volume | 2,571,234 | |||||
